FFT Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,406
Closed -$202K 67
2021
Q3
$202K Buy
3,406
+60
+2% +$3.95K 0.02% 89
2021
Q2
$224K Buy
+3,346
New +$218K 0.05% 58

Other funds holding BMY

FFT Wealth Management's BMY Position: Q4 2021 in Review

FFT Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2021, closing a stake of 3,406 shares — an estimated $202K sold.

FFT Wealth Management first reported a position in BMY in Q2 2021 and held it in 2 quarters. The position peaked at $224K in Q2 2021. 2,444 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • FFT Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2021 after selling out during the quarter.
  • FFT Wealth Management sold 3,406 Bristol-Myers Squibb shares in Q4 2021, an estimated $202K.
  • FFT Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2021 and held it in 2 quarters.
  • FFT Wealth Management's Bristol-Myers Squibb position peaked at $224K in Q2 2021.
  • 2,444 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on FFT Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.